Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06780436 · ClinicalTrials.gov registry record
3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) Instrument for Point-of-Care Diagnosis of Intracranial Hemorrhages
A clinical trial of Traumatic Brain Injury and Intracranial Hemorrhages, sponsored by The Geneva Foundation.
- Active
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06780436 is a study of Traumatic Brain Injury and Intracranial Hemorrhages that is active but no longer recruiting, run by The Geneva Foundation. The registered enrollment target is 20 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06780436, a study of Traumatic Brain Injury and Intracranial Hemorrhages, is active but no longer recruiting, sponsored by The Geneva Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to assess the safety of the 3D Transcranial Ultrasound Brain Imaging (3D TRUBI) device in Traumatic Brain Injury (TBI) patients with intracranial hemorrhage (ICH). The secondary objective is to assess the diagnostic potential of 3D TRUBI. The latter will be achieved by comparison of 3D TRUBI scans with admission head computed tomography (CT), the standard of care diagnostic modality. Demonstrating the feasibility and safety of the 3D TRUBI system is the first step toward expanding access of an alternative to CT for diagnostic imaging and triage of mass casualties of war or natural disasters in the field and in rapidly deployed medical centers or other austere environments.
Conditions Studied
Interventions
- DEVICE 3D Transcranial Ultrasound Brain Imaging
Study Locations (1)
Texas
- Brooke Army Medical Center - Fort Sam Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-12-04 |
| Est. Completion | 2026-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06780436
The ClinicalTrials.gov registry entry for NCT06780436 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (93% lower). The listed sponsor is The Geneva Foundation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which 3D Transcranial Ultrasound Brain Imaging is the first listed.
NCT06780436 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06780436 about?
NCT06780436 is a clinical study titled "3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) Instrument for Point-of-Care Diagnosis of Intracranial Hemorrhages". The primary objective of this study is to assess the safety of the 3D Transcranial Ultrasound Brain Imaging (3D TRUBI) device in Traumatic Brain Injury (TBI) patients with intracranial hemorrhage (ICH). The secondary objective is to assess the diagnostic potential of 3D TRUBI. The latter will be ach...
What is the current status of trial NCT06780436?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2024-12-04. Estimated completion is 2026-09.
What conditions does trial NCT06780436 study?
This clinical trial studies the following conditions: Traumatic Brain Injury, Intracranial Hemorrhages, Traumatic Brain Hemorrhage, Ultrasound Exams, 3D Sonography.
What interventions are being tested in trial NCT06780436?
The interventions under investigation include: 3D Transcranial Ultrasound Brain Imaging (DEVICE).
Who is sponsoring clinical trial NCT06780436?
This trial is sponsored by The Geneva Foundation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06780436 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Traumatic Brain Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
tPBM in Older Adults With Traumatic Brain Injury
RECRUITING · NA
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Carbon Dioxide Administration and Brain Waste Clearance
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Cortical Spreading Depolarization After Severe Traumatic Brain Injury
RECRUITING
-
A Study to Evaluate the SENSE Device's Ability to Detect TBI
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.